Stay updated on Benralizumab in Hypereosinophilic Syndrome Clinical Trial
Sign up to get notified when there's something new on the Benralizumab in Hypereosinophilic Syndrome Clinical Trial page.

Latest updates to the Benralizumab in Hypereosinophilic Syndrome Clinical Trial page
- Check3 days agoChange DetectedRevision: v3.4.1 released, replacing v3.4.0; no core content or study details are affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page revision label updated from v3.3.3 to v3.3.4, with no changes to trial content or details; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check46 days agoChange DetectedLocations section was added with Maryland as a location, and the page revision was updated to v3.3.3. The Maryland Locations subsection and the HHS Vulnerability Disclosure link were removed, and the previous revision v3.3.2 was deleted.SummaryDifference0.2%

- Check75 days agoChange DetectedPublication notes were updated to indicate that PubMed automatically fills the list; the revision tag changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check83 days agoChange DetectedNotice about lapse in government funding and related operating status details was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check104 days agoChange DetectedBoth screenshots preserve the core study information (overview, eligibility criteria, primary and secondary outcomes, locations) with only minor formatting/layout differences. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Benralizumab in Hypereosinophilic Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Benralizumab in Hypereosinophilic Syndrome Clinical Trial page.